Alcon makes a move for WaveLight

Article

Alcon has announced its intention to acquire WaveLight AG by means of a friendly takeover, with both parties entering into a business combination agreement.

Alcon has announced its intention to acquire WaveLight AG by means of a friendly takeover, with both parties entering into a business combination agreement.

Alcon will reportedly offer €10 per share in cash for all issued WaveLight shares. WaveLight's Executive Committee reportedly supports the transaction and will recommend to the shareholders that it be accepted, subject to a review of the published tender offer document.

The deal will be contingent on the fulfilment of various terms and conditions, including a minimum acceptance threshold of 75% of WaveLight's issued shares and approval by the relevant merger control authorities.

Related Videos
Ramin Tadayoni, MD, speaks with Sheryl Stevenson
Jennifer I. Lim, MD, FARVO, FASRS, Director of Retina Service, University of Illinois at Chicago
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center
Carl D. Regillo, MD, FACS, FASRS, Chief of Retina Service, Wills Eye Hospital, Philadelphia, PA
Arshad Khanani, MD, MA FASRS, on a virtual call
Penny A Asbell, MD, FACS speaks at the 2023 AAO meeting
© 2024 MJH Life Sciences

All rights reserved.